CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus
CROCuS,一项评估利利马托韦治疗年龄≥28天至≤3岁呼吸道合胞病毒急性呼吸道感染患儿的抗病毒活性、临床疗效和安全性的II期研究
期刊:Pediatric Drugs
影响因子:3.3
doi:10.1007/s40272-024-00625-x
Ferrero, Fernando; Lin, Chien-Yu; Liese, Johannes; Luz, Kleber; Stoeva, Tatyana; Nemeth, Agnes; Gijón, Manuel; Calvo, Cristina; Natalini, Silvina; Toh, Teck-Hock; Deleu, Sofie; Chen, Bohang; Rusch, Sarah; Sánchez, Beatriz López; Leipoldt, Illse; Vijgen, Leen; Huntjens, Dymphy; Baguet, Tristan; Bertzos, Kristi; Gamil, Mohamed; Stevens, Marita